IS7728A - Aðferð til að framleiða kalsíumsalt rósuvastatíns - Google Patents

Aðferð til að framleiða kalsíumsalt rósuvastatíns

Info

Publication number: IS7728A
Authority: IS; Iceland
Prior art keywords: preparation; calcium salt; rosuvastatin calcium; rosuvastatin; salt
Prior art date: 2002-08-13

Application number

IS7728A

Other languages

English (en)

Inventor

Horbury John

Philip Taylor Nigel

Original Assignee

Astrazeneca Uk Limited

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-08-13

Filing date

2005-03-08

Publication date

2005-03-08

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9942204&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IS7728(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2005-03-08 Application filed by Astrazeneca Uk Limited filed Critical Astrazeneca Uk Limited

2005-03-08 Publication of IS7728A publication Critical patent/IS7728A/is

Links

LALFOYNTGMUKGG-BGRFNVSISA-L rosuvastatin calcium Chemical class [Ca+2].CC(C)C1=NC(N(C)S(C)(=O)=O)=NC(C=2C=CC(F)=CC=2)=C1\C=C\[C@@H](O)C[C@@H](O)CC([O-])=O.CC(C)C1=NC(N(C)S(C)(=O)=O)=NC(C=2C=CC(F)=CC=2)=C1\C=C\[C@@H](O)C[C@@H](O)CC([O-])=O LALFOYNTGMUKGG-BGRFNVSISA-L 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Diabetes (AREA)
Hematology (AREA)
Obesity (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

IS7728A 2002-08-13 2005-03-08 Aðferð til að framleiða kalsíumsalt rósuvastatíns IS7728A (is)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB0218781.3A GB0218781D0 (en)	2002-08-13	2002-08-13	Chemical process
PCT/GB2003/003463 WO2004014872A1 (en)	2002-08-13	2003-08-07	Process for preparing the calcium salt of rosuvastatin

Publications (1)

Publication Number	Publication Date
IS7728A true IS7728A (is)	2005-03-08

Family

ID=9942204

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS7728A IS7728A (is)	2002-08-13	2005-03-08	Aðferð til að framleiða kalsíumsalt rósuvastatíns

Country Status (29)

Country	Link
US (2)	US7511140B2 (is)
EP (1)	EP1539711B1 (is)
JP (1)	JP4588446B2 (is)
KR (1)	KR101325827B1 (is)
CN (1)	CN100361979C (is)
AR (1)	AR040868A1 (is)
AT (1)	ATE501125T1 (is)
AU (1)	AU2003251369B2 (is)
BR (1)	BR0313394A (is)
CA (1)	CA2495296C (is)
CY (1)	CY1112412T1 (is)
DE (1)	DE60336326D1 (is)
DK (1)	DK1539711T3 (is)
ES (1)	ES2361009T3 (is)
GB (1)	GB0218781D0 (is)
IL (1)	IL166626A (is)
IS (1)	IS7728A (is)
MX (1)	MXPA05001582A (is)
MY (1)	MY135301A (is)
NO (1)	NO329439B1 (is)
NZ (1)	NZ538070A (is)
PL (1)	PL375296A1 (is)
PT (1)	PT1539711E (is)
RU (1)	RU2326871C2 (is)
SI (1)	SI1539711T1 (is)
TW (1)	TWI316058B (is)
UA (1)	UA83805C2 (is)
WO (1)	WO2004014872A1 (is)
ZA (1)	ZA200500745B (is)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6733780B1 (en)	1999-10-19	2004-05-11	Genzyme Corporation	Direct compression polymer tablet core
GB0003305D0 (en)	2000-02-15	2000-04-05	Zeneca Ltd	Pyrimidine derivatives
GB0011120D0 (en) *	2000-05-09	2000-06-28	Avecia Ltd	Process
NL1015744C2 (nl) *	2000-07-19	2002-01-22	Dsm Nv	Werkwijze voor de bereiding van 2-(6-gesubstitueerde-1,3-dioxan-4-yl) azijnzuurderivaten.
AU2002318041B2 (en) *	2001-07-13	2008-01-03	Astrazeneca Uk Limited	Preparation of aminopyrimidine compounds
EP1323717A1 (en)	2001-12-27	2003-07-02	Dsm N.V.	Process for the preparation of 2-(6-Substituted-1,3-Dioxane-4-yL) acetic acid derivatives
EP1375493A1 (en)	2002-06-17	2004-01-02	Dsm N.V.	Process for the preparation of an dioxane acetic acid ester
GB0218781D0 (en)	2002-08-13	2002-09-18	Astrazeneca Ab	Chemical process
KR101060215B1 (ko)	2002-12-16	2011-08-29	아스트라제네카 유케이 리미티드	피리미딘 화합물의 제조 방법
GB0312896D0 (en) *	2003-06-05	2003-07-09	Astrazeneca Ab	Chemical process
CA2537271A1 (en) *	2003-08-28	2005-03-17	Teva Pharmaceutical Industries, Ltd.	Process for preparation of rosuvastatin calcium
UY28501A1 (es) *	2003-09-10	2005-04-29	Astrazeneca Uk Ltd	Compuestos químicos
GB0321827D0 (en) *	2003-09-18	2003-10-15	Astrazeneca Uk Ltd	Chemical compounds
GB0324791D0 (en) *	2003-10-24	2003-11-26	Astrazeneca Ab	Chemical process
TW200526596A (en)	2003-11-24	2005-08-16	Teva Pharma	Crystalline ammonium salts of rosuvastatin
EP1689723B1 (en)	2003-12-02	2011-04-27	Teva Pharmaceutical Industries, Ltd.	Reference standard for characterization of rosuvastatin
EP1737828A1 (en) *	2004-01-19	2007-01-03	Ranbaxy Laboratories Limited	Amorphous magnesium salts of rosuvastatin
US7241800B2 (en)	2004-03-17	2007-07-10	Mai De Ltd.	Anhydrous amorphous form of fluvastatin sodium
US7179916B2 (en)	2004-07-13	2007-02-20	Teva Pharmaceutical Industries Ltd.	Process for the preparation of rosuvastatin
US20080234302A1 (en) *	2004-09-27	2008-09-25	Mohammad Rafeeq	Novel Processes for Preparing Amorphous Rosuvastatin Calcium and a Novel Polymorphic Form of Rosuvastatin Sodium
US7985418B2 (en)	2004-11-01	2011-07-26	Genzyme Corporation	Aliphatic amine polymer salts for tableting
CA2591053C (en) *	2004-12-23	2011-03-15	Zhejiang Hisun Pharma. Co., Ltd	Pyrimidinone compounds and preparation and use thereof
GB0428328D0 (en)	2004-12-24	2005-02-02	Astrazeneca Uk Ltd	Chemical process
JP2008528542A (ja) *	2005-01-31	2008-07-31	チバホールディングインコーポレーテッド	ロスバスタチンカルシウム塩の結晶形
TWI353981B (en)	2005-02-22	2011-12-11	Teva Pharma	Preparation of rosuvastatin
WO2006136407A1 (en) *	2005-06-24	2006-12-28	Lek Pharmaceuticals D.D.	Process for preparing amorphous rosuvastatin calcium free of impurities
WO2006136408A2 (en)	2005-06-24	2006-12-28	Lek Pharmaceuticals D.D.	Process for preparing pure amorphous rosuvastatin calcium
GB0514078D0 (en) *	2005-07-08	2005-08-17	Astrazeneca Uk Ltd	Chemical process
CA2617805A1 (en) *	2005-08-04	2007-02-15	Transform Pharmaceuticals, Inc.	Novel formulations comprising fenofibrate and a statin, and related methods of treatment
EP1919880A2 (en)	2005-08-16	2008-05-14	Teva Pharmaceutical Industries Ltd.	Rosuvastatin calcium with a low salt by-product content
EP1805148A2 (en)	2005-08-16	2007-07-11	Teva Pharmaceutical Industries Ltd.	Crystalline rosuvastatin intermediate
WO2007035313A2 (en)	2005-09-15	2007-03-29	Genzyme Corporation	Sachet formulation for amine polymers
WO2007125547A2 (en)	2006-05-03	2007-11-08	Manne Satyanarayana Reddy	Novel process for statins and its pharmaceutically acceptable salts thereof
US8404841B2 (en)	2006-10-09	2013-03-26	Msn Laboratories Limited	Process for the preparation of statins and their pharmaceutically acceptable salts thereof
WO2008053334A2 (en) *	2006-10-31	2008-05-08	Aurobindo Pharma Limited	An improved process for preparing rosuvastatin calcium
TW200831469A (en) *	2006-12-01	2008-08-01	Astrazeneca Uk Ltd	Chemical process
US8212034B2 (en)	2006-12-13	2012-07-03	Aurobindo Pharma Ltd.	Process for preparing rosuvastatin calcium
WO2008096257A1 (en) *	2007-02-08	2008-08-14	Aurobindo Pharma Limited	An improved process for preparation of rosuvastatin calcium
EP2178890A1 (en) *	2007-07-12	2010-04-28	Teva Pharmaceutical Industries Ltd.	Purification of rosuvastatin intermediate by thin film evaporation and chemical method
HU230981B1 (hu) *	2007-10-12	2019-08-28	Egis Gyógyszergyár Nyilvánosan Működő Részvénytársaság	Eljárás rosuvastatin só előállítására
HU230637B1 (hu) *	2007-10-12	2017-05-29	Egis Gyógyszergyár Nyilvánosan Működő Részvénytársaság	Eljárás rosuvastatin intermedierek előállítására
WO2009143776A1 (zh)	2008-05-27	2009-12-03	常州制药厂有限公司	瑞舒伐他汀钙盐的制备方法及其中间体
WO2010035284A2 (en) *	2008-09-26	2010-04-01	Matrix Laboratories Ltd	An improved process for the preparation of rosuvastatin calcium
US8394956B2 (en) *	2008-09-30	2013-03-12	Aurobindo Pharma Ltd.	Process for preparing pyrimidine propenaldehyde
EA021942B1 (ru)	2009-01-15	2015-10-30	Эгиш Дьёдьсердьяр Зрт.	Способ изготовления солей розувастатина
US8487105B2 (en)	2009-01-19	2013-07-16	Msn Laboratories Limited	Process for preparing pitavastatin, intermediates and pharmaceuctically acceptable salts thereof
US8987444B2 (en)	2010-01-18	2015-03-24	Msn Laboratories Private Limited	Process for the preparation of amide intermediates and their use thereof
CA2796964A1 (en)	2010-04-23	2011-10-27	Ranbaxy Laboratories Limited	Intermediates for the preparation of hmg-coa reductase inhibitors
HU230987B1 (hu)	2010-11-29	2019-08-28	Egis Gyógyszergyár Nyrt.	Eljárás nagy tisztaságú gyógyszeripari intermedierek előállítására
US9676729B2 (en) *	2013-03-29	2017-06-13	Dsm Sinochem Pharmaceuticals Netherlands B.V.	Amine salts of pitavastatin and rosuvastatin
TWM477638U (zh) *	2013-12-12	2014-05-01	三緯國際立體列印科技股份有限公司	加熱平台與立體列印裝置
JP2020507621A (ja)	2017-01-23	2020-03-12	ドンファファーマシューティカルカンパニーリミテッド	ＨＭＧ−ＣｏＡ還元酵素阻害剤およびクロピドグレルを含む複合製剤
PH12021552979A1 (en)	2019-05-27	2023-10-09	Immatics Us Inc	Viral vectors and their use in adoptive cellular therapy
DE102020111571A1 (de)	2020-03-11	2021-09-16	Immatics US, Inc.	Wpre-mutantenkonstrukte, zusammensetzungen und zugehörige verfahren
US20220056411A1 (en)	2020-08-21	2022-02-24	Immatics US, Inc.	Methods for isolating cd8+ selected t cells
SI26268A (sl)	2021-11-18	2023-05-31	Zupet Rok	Postopek za pripravo hidratirane oblike perindopril l-arginina

Family Cites Families (72)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US663641A (en) *	1900-10-11	1900-12-11	Charles A Ruebekam	Burial-casket.
US4645858A (en)	1982-03-22	1987-02-24	G. D. Searle & Co.	Pentanedioic acid derivatives
DE3741509A1 (de)	1987-12-08	1989-06-22	Hoechst Ag	Verfahren zur herstellung optisch aktiver 3-desmethylmevalonsaeurederivate sowie zwischenprodukte
AU3214689A (en)	1988-10-06	1990-05-01	Sandoz Ag	Pyrimidinyl-substituted hydroxyacids, lactones and esters and pharmaceutical compositions containing them
US5026698A (en)	1988-11-02	1991-06-25	Nissan Chemical Industries, Ltd.	Thienopyridine type mevalonolactones
JP2648897B2 (ja) *	1991-07-01	1997-09-03	塩野義製薬株式会社	ピリミジン誘導体
WO1993008823A1 (en)	1991-11-06	1993-05-13	Tanabe Seiyaku Co., Ltd.	Guanidinyl and related cell adhesion modulation compounds
US5278313A (en)	1992-03-27	1994-01-11	E. R. Squibb & Sons, Inc.	Process for the preparation of 1,3-dioxane derivatives useful in the preparation of HMG-COA reductase inhibitors
DK0577040T3 (da)	1992-07-02	1998-02-02	Hoechst Ag	Fremgangsmåde til fremstilling af (3R,5S)6-hydroxy-3,,5-O-isopropyliden-3,5-dihydroxyhexansyre-tert.-butylester
SI1148049T1 (en)	1995-07-17	2005-02-28	Warner-Lambert Company	Crystalline R-(R,R)$-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4- (phenylamino)carbonyl -1H-pyrrole-1-heptanoic acid hemi calcium salt (atorvastatin)
FR2741620B1 (fr)	1995-11-28	1997-12-26	Oreal	Procede de preparation de composes a groupement beta-hydroxy -delta-lactone analogues de la (+) compactine et de la (+) mevinoline
US6278001B1 (en)	1995-11-28	2001-08-21	L'oréal	Method for preparing (+) compactin and (+) mevinolin analog compounds having a β-hydroxy-δ-lactone grouping
PT907639E (pt)	1996-06-24	2003-06-30	Novartis Ag	Compostos polimorficos
HUP0103021A3 (en)	1998-12-10	2002-04-29	Kaneka Corp	Process for producing simvastatin derivatives
GB9900339D0 (en) *	1999-01-09	1999-02-24	Zeneca Ltd	Chemical compounds
GB9903472D0 (en) *	1999-02-17	1999-04-07	Zeneca Ltd	Chemical process
CZ304307B6 (cs) *	1999-07-13	2014-02-26	Lonza Ag	Způsob výroby 2-amino-4-(4-fluorfenyl)-6-alkyl-pyrimidin-5-karboxylátu
WO2001022962A1 (en)	1999-09-30	2001-04-05	Merck & Co., Inc.	Anti-hypercholesterolemic drug combination
DE60018100T2 (de)	1999-11-17	2005-09-15	Teva Pharmaceutical Industries Ltd.	Polymorphe form von atorvastatin-calcium
GB0001621D0 (en)	2000-01-26	2000-03-15	Astrazeneca Ab	Pharmaceutical compositions
GB0003305D0 (en) *	2000-02-15	2000-04-05	Zeneca Ltd	Pyrimidine derivatives
AU2000254249A1 (en)	2000-03-28	2001-10-08	Biocon India Limited	Synthesis of (r-(r,r))-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-
GB0011120D0 (en) *	2000-05-09	2000-06-28	Avecia Ltd	Process
GB0011163D0 (en) *	2000-05-10	2000-06-28	Astrazeneca Ab	Chemical compound
NL1015744C2 (nl)	2000-07-19	2002-01-22	Dsm Nv	Werkwijze voor de bereiding van 2-(6-gesubstitueerde-1,3-dioxan-4-yl) azijnzuurderivaten.
IL155194A0 (en)	2000-10-05	2003-11-23	Biogal Pharmaceutical Co Ltd	Pravastatin sodium substantially free of pravastatin lactone and epi-pravastatin, and compositions containing same
IL155890A0 (en)	2000-11-16	2003-12-23	Teva Pharma	HYDROLYSIS OF [R(R,R)]-2-(4-FLUOROPHENYL)-beta,delta-DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4-[(PHENYLAMINO)CARBONYL]-1H-PYRROLE-1-HEPTANOIC ACID ESTERS WITH CALCIUM HYDROXIDE
US6777552B2 (en)	2001-08-16	2004-08-17	Teva Pharmaceutical Industries, Ltd.	Processes for preparing calcium salt forms of statins
IL156055A0 (en)	2000-11-30	2003-12-23	Teva Pharma	Novel crystal forms of atorvastatin hemi calcium and processes for their preparation as well as novel processes for preparing other forms
NL1017548C2 (nl)	2001-03-09	2002-09-10	Synthon Bv	Een lactonisatie proces.
IN190564B (is)	2001-04-11	2003-08-09	Cadila Heathcare Ltd
IL158525A0 (en)	2001-06-06	2004-05-12	Bristol Myers Squibb Co	A process for preparing chiral diol sulfone derivatives
AU2002318041B2 (en) *	2001-07-13	2008-01-03	Astrazeneca Uk Limited	Preparation of aminopyrimidine compounds
AU2002324715B2 (en) *	2001-08-16	2009-03-12	Teva Pharmaceutical Industries Ltd.	Processes for preparing calcium salt forms of statins
IL160043A0 (en)	2001-08-22	2004-06-20	Ciba Sc Holding Ag	Process for the preparation of indole derivatives
WO2003026573A2 (en)	2001-09-24	2003-04-03	Merck & Co., Inc.	Screening and selection methods for statin drug combinations
EP1323717A1 (en)	2001-12-27	2003-07-02	Dsm N.V.	Process for the preparation of 2-(6-Substituted-1,3-Dioxane-4-yL) acetic acid derivatives
KR100511533B1 (ko)	2002-04-09	2005-08-31	임광민	키랄 중간체, 그의 제조방법 및 그를 이용한 HMG-CoA환원저해제의 제조방법
EP1585736A2 (en)	2002-05-21	2005-10-19	Ranbaxy Laboratories, Ltd.	Process for the preparation of rosuvastatin
EP1375493A1 (en)	2002-06-17	2004-01-02	Dsm N.V.	Process for the preparation of an dioxane acetic acid ester
GB0218781D0 (en) *	2002-08-13	2002-09-18	Astrazeneca Ab	Chemical process
US7566782B2 (en)	2002-12-10	2009-07-28	Ranbaxy Laboratories Limited	Process for the preparation of rosuvastatin
KR101060215B1 (ko) *	2002-12-16	2011-08-29	아스트라제네카 유케이 리미티드	피리미딘 화합물의 제조 방법
EA013500B1 (ru)	2003-04-11	2010-06-30	Лек Фармасьютиклз Д.Д.	Способ получения аморфной кальциевой соли аторвастатина
WO2004103977A2 (en)	2003-05-21	2004-12-02	Ciba Specialty Chemicals Holding Inc.	Process for the preparation of pyrimidine derivatives
GB0312896D0 (en)	2003-06-05	2003-07-09	Astrazeneca Ab	Chemical process
AU2003247327A1 (en)	2003-07-15	2005-01-28	Eos Eczacibasi Ozgun Kimyasal Urunler Sanyi Ve Ticaret A.S.	Process for the preparation of amortphous atorvastatin calcium without interconversion of any crystalline form
CA2537271A1 (en)	2003-08-28	2005-03-17	Teva Pharmaceutical Industries, Ltd.	Process for preparation of rosuvastatin calcium
UY28501A1 (es)	2003-09-10	2005-04-29	Astrazeneca Uk Ltd	Compuestos químicos
GB0321827D0 (en)	2003-09-18	2003-10-15	Astrazeneca Uk Ltd	Chemical compounds
GB0322552D0 (en)	2003-09-26	2003-10-29	Astrazeneca Uk Ltd	Therapeutic treatment
EP1678148A1 (en)	2003-10-22	2006-07-12	Ranbaxy Laboratories Limited	Process for the preparation of amorphous rosuvastatin calcium
GB0324791D0 (en)	2003-10-24	2003-11-26	Astrazeneca Ab	Chemical process
DE10352659B4 (de)	2003-11-11	2007-09-13	Ratiopharm Gmbh	Verfahren zur Herstellung von Statinen und Tetrahydropyranonderivate zur Verwendung in dem Verfahren
US7028631B2 (en) *	2003-11-24	2006-04-18	The Boeing Company	Gliding submersible transport system
TW200526596A (en)	2003-11-24	2005-08-16	Teva Pharma	Crystalline ammonium salts of rosuvastatin
EP1689723B1 (en)	2003-12-02	2011-04-27	Teva Pharmaceutical Industries, Ltd.	Reference standard for characterization of rosuvastatin
WO2005054207A1 (en)	2003-12-04	2005-06-16	Glenmark Pharmaceuticals Limited	Process for the preparation of pyrimidine derivatives
CA2645396A1 (en)	2003-12-24	2005-07-14	Teva Pharmaceutical Industries, Ltd	Process for preparation of statins with high syn to anti ratio
CZ200486A3 (cs)	2004-01-16	2005-08-17	Zentiva, A.S.	Způsob výroby hemivápenaté soli (E)-7-[4-(4-fluorfenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl](3R,5S)-3,5-dihydroxy-6-heptenové kyseliny
EP1737828A1 (en)	2004-01-19	2007-01-03	Ranbaxy Laboratories Limited	Amorphous magnesium salts of rosuvastatin
EP1709008A1 (en)	2004-01-19	2006-10-11	Ranbaxy Laboratories Limited	Salts of hmg-coa reductase inhibitors and use thereof
US7241800B2 (en)	2004-03-17	2007-07-10	Mai De Ltd.	Anhydrous amorphous form of fluvastatin sodium
GB0406757D0 (en)	2004-03-26	2004-04-28	Avecia Ltd	Process and compounds
US7161004B2 (en)	2004-06-21	2007-01-09	Dr. Reddy's Laboratories Limited	Processes to produce intermediates for rosuvastatin
US7179916B2 (en)	2004-07-13	2007-02-20	Teva Pharmaceutical Industries Ltd.	Process for the preparation of rosuvastatin
US20080234302A1 (en)	2004-09-27	2008-09-25	Mohammad Rafeeq	Novel Processes for Preparing Amorphous Rosuvastatin Calcium and a Novel Polymorphic Form of Rosuvastatin Sodium
GB0428328D0 (en) *	2004-12-24	2005-02-02	Astrazeneca Uk Ltd	Chemical process
JP2008528542A (ja)	2005-01-31	2008-07-31	チバホールディングインコーポレーテッド	ロスバスタチンカルシウム塩の結晶形
CA2498978A1 (en)	2005-02-28	2006-08-28	Apotex Pharmachem Inc.	An improved process for the preparation of atorvastatin and intermediates
GB0514078D0 (en) *	2005-07-08	2005-08-17	Astrazeneca Uk Ltd	Chemical process
TW200831469A (en) *	2006-12-01	2008-08-01	Astrazeneca Uk Ltd	Chemical process

2002
- 2002-08-13 GB GBGB0218781.3A patent/GB0218781D0/en not_active Ceased
2003
- 2003-07-08 UA UAA200500711A patent/UA83805C2/uk unknown
- 2003-08-07 ES ES03784274T patent/ES2361009T3/es not_active Expired - Lifetime
- 2003-08-07 CN CNB038239949A patent/CN100361979C/zh not_active Expired - Lifetime
- 2003-08-07 PL PL03375296A patent/PL375296A1/xx unknown
- 2003-08-07 US US10/524,235 patent/US7511140B2/en not_active Expired - Lifetime
- 2003-08-07 SI SI200331993T patent/SI1539711T1/sl unknown
- 2003-08-07 WO PCT/GB2003/003463 patent/WO2004014872A1/en not_active Ceased
- 2003-08-07 DE DE60336326T patent/DE60336326D1/de not_active Expired - Lifetime
- 2003-08-07 DK DK03784274.7T patent/DK1539711T3/da active
- 2003-08-07 NZ NZ538070A patent/NZ538070A/en not_active IP Right Cessation
- 2003-08-07 KR KR1020057002408A patent/KR101325827B1/ko not_active Expired - Lifetime
- 2003-08-07 AT AT03784274T patent/ATE501125T1/de active
- 2003-08-07 BR BR0313394-0A patent/BR0313394A/pt not_active IP Right Cessation
- 2003-08-07 JP JP2004527041A patent/JP4588446B2/ja not_active Expired - Lifetime
- 2003-08-07 PT PT03784274T patent/PT1539711E/pt unknown
- 2003-08-07 CA CA2495296A patent/CA2495296C/en not_active Expired - Fee Related
- 2003-08-07 MX MXPA05001582A patent/MXPA05001582A/es active IP Right Grant
- 2003-08-07 TW TW092121663A patent/TWI316058B/zh not_active IP Right Cessation
- 2003-08-07 RU RU2005102391/04A patent/RU2326871C2/ru active
- 2003-08-07 AU AU2003251369A patent/AU2003251369B2/en not_active Expired
- 2003-08-07 EP EP03784274A patent/EP1539711B1/en not_active Revoked
- 2003-08-11 MY MYPI20033048A patent/MY135301A/en unknown
- 2003-08-13 AR AR20030102929A patent/AR040868A1/es unknown
2005
- 2005-01-31 NO NO20050542A patent/NO329439B1/no not_active IP Right Cessation
- 2005-02-01 IL IL166626A patent/IL166626A/en unknown
- 2005-03-08 IS IS7728A patent/IS7728A/is unknown
2006
- 2006-01-10 ZA ZA200500745A patent/ZA200500745B/en unknown
2009
- 2009-02-13 US US12/371,359 patent/US7842807B2/en not_active Expired - Lifetime
2011
- 2011-05-09 CY CY20111100442T patent/CY1112412T1/el unknown

Also Published As

Publication number	Publication date
SI1539711T1 (sl)	2011-06-30
JP4588446B2 (ja)	2010-12-01
IL166626A0 (en)	2006-01-15
JP2006500347A (ja)	2006-01-05
WO2004014872A1 (en)	2004-02-19
KR20050036968A (ko)	2005-04-20
PL375296A1 (en)	2005-11-28
NZ538070A (en)	2006-08-31
EP1539711B1 (en)	2011-03-09
AU2003251369B2 (en)	2007-02-01
KR101325827B1 (ko)	2013-11-05
CA2495296A1 (en)	2004-02-19
US20060116391A1 (en)	2006-06-01
AU2003251369A1 (en)	2004-02-25
US20090286819A1 (en)	2009-11-19
MY135301A (en)	2008-03-31
MXPA05001582A (es)	2005-04-25
UA83805C2 (uk)	2008-08-26
DK1539711T3 (da)	2011-05-30
RU2326871C2 (ru)	2008-06-20
ES2361009T3 (es)	2011-06-13
DE60336326D1 (de)	2011-04-21
RU2005102391A (ru)	2005-10-10
TW200404786A (en)	2004-04-01
CN1688551A (zh)	2005-10-26
ZA200500745B (en)	2006-03-29
CN100361979C (zh)	2008-01-16
EP1539711A1 (en)	2005-06-15
US7842807B2 (en)	2010-11-30
AR040868A1 (es)	2005-04-20
US7511140B2 (en)	2009-03-31
TWI316058B (en)	2009-10-21
CY1112412T1 (el)	2015-12-09
NO20050542L (no)	2005-02-28
ATE501125T1 (de)	2011-03-15
HK1082735A1 (zh)	2006-06-16
GB0218781D0 (en)	2002-09-18
NO329439B1 (no)	2010-10-18
IL166626A (en)	2011-09-27
CA2495296C (en)	2011-05-03
BR0313394A (pt)	2005-06-21
PT1539711E (pt)	2011-05-03

Publication	Publication Date	Title
IS7728A (is)	2005-03-08	Aðferð til að framleiða kalsíumsalt rósuvastatíns
NO20041082L (no)	2004-03-15	Fremgangsmater for fremstilling av kalsiumsaltformer av statiner
IS8217A (is)	2006-01-02	Bætt framleiðsla rósúvastatínkalsíumsalts
IL173858A0 (en)	2006-07-05	Process for preparation of rosuvastatin calcium
HUP0500851A3 (en)	2008-02-28	Process for the preparation of rosuvastatin
NO20050136D0 (no)	2005-01-11	Fremgangsmate for fremstilling av mikropartikler
DK1803718T3 (da)	2008-10-27	4-Tetrazolyl-4-phenylpiperidin-derivater til behandling af smerter
DK1546122T3 (da)	2008-03-03	Fremgangsmåde til fremstilling af valsartan
PT1578731E (pt)	2010-01-12	Processo para a preparação de compostos pirimidina
DK1678135T3 (da)	2009-09-07	Fremgangsm de til fremstilling af n-amino-substituerede hetorocykliske forbindelser
NO20034597D0 (no)	2003-10-14	Fremgangsmåte for fremstilling av cantaxantin
ITMI20020933A0 (it)	2002-05-03	Procedimento per la sintesi di clopidogrel
DK1511724T3 (da)	2014-06-16	Fremgangsmåde til fremstilling af thioalkylaminderivater
DK1692137T3 (da)	2007-04-30	Fremgangsmåde til fremstilling af tubulinininhibitorer
NO20044332L (no)	2005-01-17	Forbedret fremgangsmate for fremstilling av nevirapine
ITMI20031994A1 (it)	2005-04-16	Procedimento per la preparazione di fludarabina fosfato
ITMI20030018A1 (it)	2004-07-10	Procedimento per la preparazione di composti mono-
DK1497290T3 (da)	2008-12-15	Fremgangsmåde til fremstilling af syresalte af gemifloxacin
EP1477477A4 (en)	2006-04-19	PROCESS FOR THE PREPARATION OF CAROTENOIDS
ITMI20030019A1 (it)	2004-07-10	Procedimento per la preparazione di composti mono-
FR2835839B1 (fr)	2004-04-02	Procede de preparation de la 7beta-hydroxy-dehydroepiandrosterone
FI20031420A7 (fi)	2003-10-01	Menetelmä uusien 7-substituoitu-9-(substituoitu amino)-6-demetyyli-6-deoksitetrasykliinien valmistamiseksi
ITMI20020620A1 (it)	2003-09-26	Procedimento per la preparazione di alchil-benzoati per esterificazione di benzoil-fluoruri
ITMO20020179A0 (it)	2002-06-25	Impianto perfezionato per la preparazione di calcestruzzo
NO20054977D0 (no)	2005-10-26	Fremgangsmate for fremstilling av imidazopyridin-8-oner